Gaia posted double-digit year-over-year revenue growth, driven in part by an increase in the streaming video provider’s ...

OnKure's drug candidate pipeline is highlighted by OKI-219, a selective PI3K alpha H1047R inhibitor for the treatment of certain types of breast cancer that began clinical trials in February 2024.

Kat Tretina is is an expert on student loans who started her career paying off her $35,000 student loans years ahead of schedule. Her work has been published by Experian, Credit Karma, Student ...

Events.com ("the Company"), an industry-leading event management and discovery platform, today announced the strategic acquisition of Citifyd, a premier technology provider specializing in urban and ...